Strategic Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,261
Closed -$236K 144
2017
Q4
$236K Sell
2,261
-3,991
-64% -$450K 0.1% 128
2017
Q3
$912K Buy
6,252
+3,550
+131% +$484K 0.4% 66
2017
Q2
$351K Buy
2,702
+48
+2% +$5.88K 0.16% 117
2017
Q1
$330K Buy
2,654
+444
+20% +$53.1K 0.16% 113
2016
Q4
$256K Sell
2,210
-2,750
-55% -$306K 0.13% 110
2016
Q3
$518K Buy
4,960
+580
+13% +$62.8K 0.29% 88
2016
Q2
$432K Buy
4,380
+2,350
+116% +$243K 0.25% 94
2016
Q1
$203K Buy
+2,030
New +$209K 0.12% 123

Other funds holding CELG

Strategic Advisors's CELG Position: Q1 2018 in Review

Strategic Advisors sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,261 shares — an estimated $236K sold.

Strategic Advisors first reported a position in CELG in Q1 2016 and held it in 8 quarters. The position peaked at $912K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Strategic Advisors reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Strategic Advisors sold 2,261 Celgene Corp shares in Q1 2018, an estimated $236K.
  • Strategic Advisors first reported a position in Celgene Corp in Q1 2016 and held it in 8 quarters.
  • Strategic Advisors's Celgene Corp position peaked at $912K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Strategic Advisors's 13F filing for Q1 2018, filed 19 Apr 2018.